Cite

HARVARD Citation

    Ip, C. et al. (2018). Neomorphic PDGFRA extracellular domain driver mutations are resistant to PDGFRA targeted therapies. Nature communications. 9 (1), pp. 1-14. [Online]. 
  
Back to record